AlphAIAlphAI — Financial news for AI agents
prnewswire.com$PAVM

PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026

PAVmed Inc. (Nasdaq: PAVM) will host a business update conference call on November 13, 2026, at 8:30 AM ET. CEO Lishan Aklog and CFO Dennis McGrath will discuss operations, growth strategy, and Q3 2026 financial results. The webcast will be available on the company's website, with a replay accessible for 30 days. PAVmed operates in medical devices, diagnostics, and digital health, with subsidiaries Lucid Diagnostics (Nasdaq: LUCD) and Veris Health.

Original reporting
prnewswire.com
Published Oct 30, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 — source image
Source · prnewswire.com
Decision brief

The 30-second read

$PAVMNeutralLow
01

Why it matters

The notice is a routine corporate communication with no new financial metrics, so market impact is expected to be minimal.

02

Market read

Low trading relevance; primarily a scheduling announcement with no new data.

03

What to watch

The call could hint at upcoming guidance or strategic shifts not disclosed yet.

Relevance 4/10Novelty 2/10Timing: Nov 13, 2026

Background

PAVmed Inc. issued a press release announcing a third‑quarter 2026 business update conference call and webcast to be held on November 13, 2026, with CEO Lishan Aklog and CFO Dennis McGrath speaking.

Company-level read

Ticker impact

$PAVMNeutralHigh confidence
Context

PAVmed announced a Q3 2026 business update conference call scheduled for November 13, 2026.

Expected impact

likely little to no immediate price movement

Evidence & confidence

A simple scheduling notice without earnings or guidance typically has minimal market effect.

Market effects

Sector

Minimal impact on the medical device and diagnostics sector.

Regional

No immediate regional market effect.

Global

Negligible global relevance.

Counterpoint

What could challenge this read

Some traders may overreact to any corporate update, but the lack of new data suggests limited upside.

Key entities

  • company
    PAVmed Inc.

    Diversified commercial‑stage medical technology company.

  • executive
    Lishan Aklog

    Chairman and Chief Executive Officer of PAVmed.

  • executive
    Dennis McGrath

    President and Chief Financial Officer of PAVmed.

Read at source← All news

Related articles

$PAVMMed

PAVmed (PAVM) Q2 2026 Earnings Call Transcript

PAVmed (PAVM) held its Q2 2026 earnings call. GAAP net loss was $5.5 million ($0.87/share) and non-GAAP adjusted loss was $1.7 million ($0.27/share). Revenue was $33,000, with pro forma income over $3 million. Cash was $3.8 million at June 30. Management discussed Veris, Lucid Diagnostics, and device regulatory timelines, including a targeted early-2027 510(k) submission for Veris.

fool.com
$MTVAHighAI 8/10

MetaVia Announces Statistically Significant Reduction in Uric Acid Levels with DA-1726 in Phase 1 Part 3B Clinical Trial

MetaVia Inc. (MTVA) reported additional positive data from its Phase 1 Part 3B clinical trial of DA-1726, showing a 1.47 mg/dL placebo-adjusted reduction in uric acid (p<0.001) after 16 weeks. The trial also demonstrated a 68.1% reduction in liver fat, 13.5% weight loss, and improvements in HbA1c. MetaVia plans to begin a Phase 2 study in MetALD and ALD in the second half of 2027.

prnewswire.com
$HUBSHigh

HubSpot Appoints Co-founder Brian Halligan As CEO After Yamini Rangan Steps Down

HubSpot (HUBS) announced Yamini Rangan will step down as CEO on November 12, 2026, and co-founder Brian Halligan will take over. Rangan will stay until December 1, 2026, for a smooth transition. CFO Kate Bueker will retire on February 11, 2027, and Karen Burgess will join as EVP of Finance on November 30, 2026, becoming CFO in February 2027. HubSpot reaffirmed its financial guidance for Q4 and full year 2026.

rttnews.com